What Is Immutep Limited (IMMP) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Immutep Limited's intrinsic value is estimated at a composite fair value of $0.59. At a current market price of $0.44, 7 of 9 active valuation models identify upside potential, projecting an average implied return of +35.6%. Notably, Dynamic NAV sees the most upside at +112.5% (fair value: $0.93), while ML-RIV is the most conservative at -98.3% ($0.01). The spread between these extremes — +210.8% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About IMMP?
9 of 13 models are currently active for IMMP. Of these, 7 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates IMMP's intrinsic value at $0.47, implying +8.2% upside from the current price. See which stocks rank higher →
How Does IMMP Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, IMMP ranks #175 by Quality of Company score. CirclFi's QOC score of 5.3/10 evaluates 32 fundamental signals. A score of 5.3 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a healthcare company, Immutep Limited operates in a sector where clinical trial success rate is a critical driver of valuation. Investors evaluating IMMP should weigh these sector-specific dynamics alongside our model-derived fair values.
Is IMMP a Value Trap?
CirclFi's Value Trap algorithm assigns IMMP a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Immutep Limited. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Immutep Limited's fundamental quality profile registers 5.3/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +210.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every IMMP valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across IMMP's 9 active models, average confidence is 20%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad